Integrative Health Information Unit

Alt Text

Integrative Health Information Unit

"The Integrative Health Information Unit, a unit under Herbal Medicine Research Centre (HMRC), was established in 2001 at Jalan Pahang, Kuala Lumpur, to collect and share validated information on medicinal plants that support the advancement of integrated medicine. Now based at the National Institutes of Health (NIH) Malaysia in Setia Alam, Selangor, the Unit has grown in expertise and capacity, enabling it to conduct rapid literature reviews in response to professional inquiries.

Its core function is to compile ethnomedicinal and scientific data to build a comprehensive medicinal plant database serving healthcare professionals, researchers, and the public. The Unit emphasises evidence-based resources, producing books, compendiums, monographs, infographics, technical reports, and journal publications that address current issues in herbal medicine and traditional and complementary medicine (T&CM).

Future plans include strengthening its research capabilities through staff training in in-silico techniques, which use computational approaches to explore new therapeutic potentials of medicinal plants. This initiative supports ongoing efforts to enhance herbal medicine discovery and broaden the scientific foundation for integrated healthcare practices."

Executive Summary

Head of Integrative Health Information Unit

Mr. Terence Tan Yew Chin

Master of Pharmacy (University of Strathclyde, UK), MSc Pharmaceutical Analysis (UKM, Malaysia)

Google Scholar | ResearchGate

Telephone: +603-3362 7955

Email: terencetyc@moh.gov.my

Mr. Terence Tan Yew Chin
Mr. Terence Tan Yew Chin

Human Resource Profile

01

Specialist

03

Medical Officers

03

Pharmacists

03

Research Officers

01

Support Staff

Focus Area

Disease Treatment & Management

Scope: Natural products/drug discovery/repurposing drugs.

Highlights:

  • A critical review on four medicinal plants; Nigella sativa, Vernonia amygdalina, Azadirachta indica and Eurycoma longifolia for their potential roles in COVID-19 management.

  • Rapid review was conducted to identify and evaluate the current SARS-CoV-2 antiviral evidence for Andrographis paniculata, andrographolide, and andrographolide analogs

Gallery